This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (funded, already peer-reviewed, non-eHealth) (174) Health Services Research (499) Aging with Chronic Disease (118) Diabetes Self-Management (500) Precision Medicine (79)

Published on in Vol 13 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/62667, first published .
Effect of Semaglutide on Physical Function, Body Composition, and Biomarkers of Aging in Older Adults With Overweight and Insulin Resistance: Protocol for an Open-Labeled Randomized Controlled Trial

Effect of Semaglutide on Physical Function, Body Composition, and Biomarkers of Aging in Older Adults With Overweight and Insulin Resistance: Protocol for an Open-Labeled Randomized Controlled Trial

Effect of Semaglutide on Physical Function, Body Composition, and Biomarkers of Aging in Older Adults With Overweight and Insulin Resistance: Protocol for an Open-Labeled Randomized Controlled Trial

Authors of this article:

Tiffany M Cortes1, 2, 3 Author Orcid Image ;   Libia Vasquez4 Author Orcid Image ;   Monica C Serra2, 3, 5 Author Orcid Image ;   Ronna Robbins6 Author Orcid Image ;   Allison Stepanenko2 Author Orcid Image ;   Kevin Brown2 Author Orcid Image ;   Hannah Barrus2 Author Orcid Image ;   Annalisa Campos2 Author Orcid Image ;   Sara E Espinoza5, 7, 8 Author Orcid Image ;   Nicolas Musi7, 8 Author Orcid Image
Article Authors Cited by (1) Tweetations Metrics

Journals

  1. Karakasis P, Patoulias D, Fragakis N, Mantzoros C. Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis. Metabolism 2025;164:156113 View